CO6420320A2 - Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos - Google Patents

Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos

Info

Publication number
CO6420320A2
CO6420320A2 CO11105973A CO11105973A CO6420320A2 CO 6420320 A2 CO6420320 A2 CO 6420320A2 CO 11105973 A CO11105973 A CO 11105973A CO 11105973 A CO11105973 A CO 11105973A CO 6420320 A2 CO6420320 A2 CO 6420320A2
Authority
CO
Colombia
Prior art keywords
products
amino acid
phenylpropenoil
amidas
same
Prior art date
Application number
CO11105973A
Other languages
English (en)
Inventor
Fabien Robert
Karin Kraehenbuehl
Jane Durga
Denis Marcel Barron
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CO6420320A2 publication Critical patent/CO6420320A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/10—Treating roasted coffee; Preparations produced thereby
    • A23F5/14—Treating roasted coffee; Preparations produced thereby using additives, e.g. milk, sugar; Coating, e.g. for preserving
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/56—Cocoa products, e.g. chocolate; Substitutes therefor making liquid products, e.g. for making chocolate milk drinks and the products for their preparation, pastes for spreading, milk crumb
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)

Abstract

La presente invención se refiere al uso de una composición que comprende amidas de N-fenilpropenoil amino ácido para la preparación de un producto para tratar o prevenir padecimientos neurodegenerativos, deterioro cognitivo, deterioro cognitivo moderado, demencia, alteraciones del estado de ánimo, depresión, trastornos del sueño, enfermedades que involucran agregación de proteína en un ser humano o en un animal, enfermedad de Alzheimer, degeneración macular o diabetes. La invención se refiere además a productos que comprenden amidas de N-fenilpropenoil amino ácido, que incluyen productos alimenticios y para beber, complementos alimenticios, y productos alimenticios para mascotas, y métodos para afectar el desempeño cognitivo de seres humanos y animales.
CO11105973A 2009-02-13 2011-08-19 Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos CO6420320A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09152775 2009-02-13

Publications (1)

Publication Number Publication Date
CO6420320A2 true CO6420320A2 (es) 2012-04-16

Family

ID=40800459

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11105973A CO6420320A2 (es) 2009-02-13 2011-08-19 Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos

Country Status (14)

Country Link
US (1) US20110313014A1 (es)
EP (1) EP2396083A2 (es)
JP (1) JP2012517970A (es)
KR (1) KR20110127204A (es)
CN (1) CN102405079A (es)
AU (1) AU2010212997A1 (es)
BR (1) BRPI1008427A2 (es)
CA (1) CA2752249A1 (es)
CL (1) CL2011001980A1 (es)
CO (1) CO6420320A2 (es)
MX (1) MX2011008512A (es)
RU (1) RU2011137563A (es)
WO (1) WO2010091981A2 (es)
ZA (1) ZA201106665B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2666365A1 (en) * 2012-05-22 2013-11-27 Taminco Treatment of poultry, pigs or fish for reducing the feed conversion ratio.
US10695317B2 (en) 2015-05-11 2020-06-30 Meiji Co., Ltd. Composition for promoting production of brain-derived neurotrophic factor
KR20170001011U (ko) 2015-09-09 2017-03-17 오병서 조사각 조절이 용이한 터널등기구
CN105168456A (zh) * 2015-09-16 2015-12-23 韩志强 一种安乐片
US10040551B2 (en) * 2015-12-22 2018-08-07 International Business Machines Corporation Drone delivery of coffee based on a cognitive state of an individual
US10588885B2 (en) * 2016-07-12 2020-03-17 Vidya Herbs, Inc. Chlorogenic acid composition and method for its use in the treatment of Alzheimer's disease
CN106349099B (zh) * 2016-07-29 2018-08-07 西安科技大学 咖啡酸-赖氨酸及其衍生物、制备方法和用途
CN106242987B (zh) * 2016-07-29 2019-02-22 西安科技大学 一种防治糖尿病和糖尿病肾病药物及其合成方法和应用
US10952985B2 (en) 2017-10-12 2021-03-23 Vidya Herbs, Inc. Chlorogenic acid composition for the treatment of metabolic disorders
EA036612B1 (ru) * 2018-01-19 2020-11-30 Торегельды Шарманович ШАРМАНОВ Состав для производства шоколада из кобыльего молока
CN108484431A (zh) * 2018-03-26 2018-09-04 中国药科大学 一种肉桂酰氨基酸类化合物及其用途
JP2021014414A (ja) * 2019-07-10 2021-02-12 味の素株式会社 尿酸値低減作用を有する組成物の製造方法及び医薬品
WO2021028106A2 (en) * 2019-08-15 2021-02-18 Firmenich Sa Taste-modifying compounds and uses thereof
US11896600B2 (en) 2019-09-21 2024-02-13 Vidya Herbs, Inc. Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders
CN113444015B (zh) * 2020-03-24 2022-11-08 中国药科大学 一种肉桂酰氨基酸类化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379666B1 (en) * 1999-02-24 2002-04-30 Edward L. Tobinick TNF inhibitors for the treatment of neurological, retinal and muscular disorders
DE60230262D1 (de) * 2001-05-10 2009-01-22 Ono Pharmaceutical Co Carbonsäurederivate und diese als wirkstoff enthaltende arzneimittel
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
DE102006033321A1 (de) * 2006-07-17 2008-01-24 Westfälische Wilhelms-Universität Münster Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
WO2008092091A2 (en) * 2007-01-26 2008-07-31 Jenrin Discovery Mao inhibiting n-benzyl-n-propargyl-amines useful for treating obesity

Also Published As

Publication number Publication date
EP2396083A2 (en) 2011-12-21
MX2011008512A (es) 2011-09-08
CL2011001980A1 (es) 2012-04-20
CN102405079A (zh) 2012-04-04
BRPI1008427A2 (pt) 2016-03-01
WO2010091981A3 (en) 2010-10-28
CA2752249A1 (en) 2010-08-19
US20110313014A1 (en) 2011-12-22
WO2010091981A2 (en) 2010-08-19
ZA201106665B (en) 2013-02-27
JP2012517970A (ja) 2012-08-09
RU2011137563A (ru) 2013-03-20
AU2010212997A1 (en) 2011-09-08
KR20110127204A (ko) 2011-11-24

Similar Documents

Publication Publication Date Title
CO6420320A2 (es) Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos
MX2019012081A (es) Proteina de fusion del factor de crecimiento 21 de fibroblastos humanos (hfgf21), metodo de preparacion de la misma y su uso.
ES2659353T3 (es) Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer
ES2828479T3 (es) Métodos y composiciones para tratar, reducir o prevenir el deterioro del sistema visual de los animales
BR112017009678A2 (pt) composição optimizada de nutrientes de ácidos graxos e método de preparação da mesma
BRPI0818723A2 (pt) composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição
RU2009108655A (ru) Производные лигустилида для лечения расстройств центральной нервной системы
RU2012114057A (ru) Композиции и способы усиления когнитивной функции и связанных с ней функций у животных
ES2687762T3 (es) Epicatequina para aliviar los síntomas de la alergia
WO2008071790A3 (en) Novel compositions and uses thereof
BR0213124A (pt) Alimentos para animais incluindo ativos e métodos de uso dos mesmos
BR112014018096A2 (pt) péletes compreendendo amido e proteína, processo para obtenção destes e uso dos mesmos
ES2952207T3 (es) Métodos para imitar la restricción calórica crónica y para impartir beneficios para la salud de un animal
WO2008135661A3 (fr) Utilisation de la citrulline pour pour le traitement de pathologies liees a une augmentation de la carbonylation des protéines
AR122410A1 (es) Composiciones del aceite de pongamia y métodos para su producción y uso
WO2017119481A1 (ja) 環状ジペプチド含有神経性疾患予防用組成物
JP2010254695A (ja) 人間、犬猫動物のすべて畜産のすべてミツバチ益虫のすべて鳥類のすべて樹木のすべて植物のすべての病気快復の液体
TW200633645A (en) Increase in the protein proportion of animal organisms
MX339886B (es) Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias.
JP2009507510A5 (es)
CL2011003083A1 (es) Producto alimenticio que comprende zeolita micronizada, en que al menos 90% de los granulos tienen un tamaño mayor a 0,1um; combinacion para uso en un producto alimenticio; uso de zeolita y/o clinoptilolita micronizada; harina para uso humano; y metodo para limitar la absorcion de etanol al consumir bebidas alcoholicas.
PA8567501A1 (es) Formas cristalinas de agonistas del receptor b3-adrenergico, procedimientos para su preparacion, y sus usos
TW200740825A (en) Cripowellins and synthetic derivatives thereof as medicaments
CN102793166A (zh) 一种保健食品
AR121737A1 (es) Composiciones del aceite de pongamia y métodos para su producción y uso

Legal Events

Date Code Title Description
FG Application granted